Research & Development: Page 43
-
PharmaVoice Team/PharmaVoice
Innovator's Corner
A Single Pill for Multiple Viruses The treatment of viral infections is an unmet medical need. While many viruses such as rhinoviruses, which cause the cold, are not considered serious, others, such as ebola, are. There are more than 200 viruses that cause mild-to-severe diseases that have limite...
By Lillian Chiang • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Future Breakthroughs
The PharmaVOICE 100 discuss what’s on the research and commercialization horizons The PharmaVOICE 100 honorees had much to say about where they thought future breakthroughs will be. On the development side, personalized medicine and advances in cancer immunology will create new breakthrough treat...
By Denise Myshko • July 28, 2014 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
10 Years of Honorees
PharmaVOICE Honoree Year(s) Adrian Adams 2012 Colleen Adams 2009 Julian Adams, Ph.D. 2008, 2011 Thomas Adams 2005 Jeffrey Adelglass, M.D. 2014 Lisa Adler 2014 Ann Aerts, M.D. 2014 Michael Agard 2010 Gadi Aharoni, Ph.D. 2006 Christopher Ahlberg, Ph.D. 2005 Mark J. Ahn, Ph.D. 2005 Murray L. Aitken ...
By Robin Robinson • July 28, 2014 -
PharmaVoice Team/PharmaVoice
Red Jacket Awards
In celebration of 10 years of the PharmaVOICE 100, we are proud to launch the Red Jacket Award. This honor recognizes individuals who have been nominated multiple times by their colleagues and peers as inspirational leaders. Throughout their careers, they have demonstrated a commitment to further...
By PharmaVoice Team • July 28, 2014 -
PharmaVoice Team/PharmaVoice
The Patient Advocates
John Glasspool Changing the Access Conversation Driven to innovate by People Market access is dead and the new driver of change and progress in healthcare is patient access. That’s the view of John Glasspool, who heads Baxter’s global market development program. With a dedicated focus on patient ...
By Robin Robinson • July 28, 2014 -
PharmaVoice Team/PharmaVoice
The Mentors
John White Mentor, Expert, Leader Driven to innovate by Possibilities Last year, John White ran 60-kilometers (37 miles) to celebrate his 60th birthday. Not only did he complete the race, but he used the event to create a fundraiser for the American Cancer Society (ACS). Called the 60 for 60 Race...
By Robin Robinson • July 28, 2014 -
PharmaVoice Team/PharmaVoice
The Clinical Specialists
Michael Brooks Energy for the Long Run Driven to Innovate by Instinct Michael Brooks is a visionary leader who helped create a groundbreaking way for PPD to serve the needs of its biopharmaceutical clients. Under Mr. Brooks’ direction, the company employed several state-of-the-art technologies to...
By PharmaVoice Team • July 28, 2014 -
PharmaVoice Team/PharmaVoice
PharmaVOICE 100 - Who's on the List by Section
These extraordinary leaders, representing a wide range of industry sectors and functional areas of expertise, are having a positive impact on their colleagues, their companies, and the greater healthcare community. See who you know! Who’s on the List — 2014 Indexed by Section The Academics Dr. Mo...
By Taren Grom • July 28, 2014 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts TMF Survey Reveals Lagging Technology Adoption and Use of Manual Processes Trending now: Although advanced eTMF technologies improve inspection readiness and compliance while reducing costs, a majority still use paper or electronic files...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Veeva Systems Introduces Commercial Cloud for Life Sciences Trending Now: New industry cloud brings together master data, compliant content, and customer interactions across all channels to transform commercial operations. Veeva Systems has unveiled Commercial Cloud, a next-generation solution to...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
What's New
Global Outcomes Group Launches to Support Outcomes Research Trending Now: New full-service medical communications agency focuses on supporting growing health economics and outcomes research in biopharma industry. The Global Outcomes Group has been formed to support the content and communication n...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
2014 PharmaVOICE 100 - Who's on the List by Company
Who’s on the List — 2014 Indexed by Company Affiliation AbelsonTaylor – Dr. Jeffrey Berg Advanced Clinical LLC – Susan Seroskie Advanced Clinical LLC – Julie Ross Baxter Healthcare Corp. – John Glasspool BBK Worldwide – Aaron Fleishman BioClinica Inc. – Dr. Boaz Mendzelevski Biogen Idec – Dr. Kat...
By Robin Robinson • July 28, 2014 -
PharmaVoice Team/PharmaVoice
UpFront
INDUSTRY at Large Kowa and Football Player Help those with High Cholesterol Kowa Pharmaceuticals America has announced a partnership with Kurt Warner, Super Bowl winner and two-time NFL MVP, and his wife Brenda, to launch First and Goal, a national education initiative to help people prioritize h...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The 2014 PharmaVOICE 100 The PharmaVOICE 100 Turns 10! It’s hard to believe that 10 years after the vision for this issue was captured on the back of a napkin during a long flight delay, we have now profiled 1,000 of the industry’s most inspirational and motivational individuals making this issue...
By Taren Grom • July 28, 2014 -
PharmaVoice Team/PharmaVoice
New Considerations for the Design and Execution of Immuno-Oncology Drug Trials
There is much excitement in the field of immuno-oncology drugs with the approval of sipuleucel-T (Provenge), ipilimumab (Yervoy), and the very promising data on other checkpoint modulators, new oncolytic viruses, and therapeutic vaccines on the horizon. There are some important adjustments in tre...
By Jeffrey Weisberg • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Top 10 Clinical Trial Cost-Cutting Innovations
The challenges associated with conducting and managing today’s clinical trials have never been greater. According to a recent survey, clinical trials today cost 60% more than they did five years ago. Primary cost drivers include trial site startup (i.e., training, systems setup and access, regula...
By Sandra R. Lottes • May 29, 2014 -
PharmaVoice Team/PharmaVoice
How Information Technology is Enhancing Clinical Trials Recruitment and Participation
New platforms and technology today are able to help keep the right physicians apprised of the right open trials — communicating information efficiently across multiple locations in a large geographical area. Pharmaceutical companies have long struggled to achieve clinical trial recruitment goals....
By Jeff Meehan • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Mapping Your Workforce Genome
What if you could plan out your workforce needs with the precision that we see in well-crafted R&D protocols and personalized medicine? And what if you could look at your human capital engagements and the available “talent supply chain" in the way science has started to look at sustaining hea...
By Mark A. Lanfear • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Data-Driven Approaches Accelerate Trial Recruitment and Quantify Risk
At one time, biopharmaceutical companies could develop their clinical trial recruitment strategies using nothing more than historical experience, anecdotal knowledge, and gut instinct. They could trust investigators to supply the necessary patients, and as a last resort, bolt on some media covera...
By Ramita Tandon • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Innovating Clinical Trials: Aggregating Clinical Data for Easy Access and Brilliant Insights
There are increasing pressures for life-sciences companies to look aggressively for ways to decrease costs and bring new products to market more quickly. Sponsors want to leverage their clinical data to support critical decisions. To do this clinical data need to be easily accessible and integrat...
By Raj Indupuri • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Why Investigators Hold the Cards to Clinical Trial Success
Why Investigators Hold the Cards to Clinical Trial Success “Including experienced investigators early in the process of writing a protocol would help prevent common issues that hinder trial enrollment and retention" said a clinical trial investigator from Jacksonville, Fla. Clinical trials demand...
By Dr. Claire Sears • May 29, 2014 -
PharmaVoice Team/PharmaVoice
The New Face of Informed Consent: It's More Than A Signature
Contributed by: Marc Sirockman, Executive Vice President & General Manager Artcraft Health and Lisa Moss Calderwood, MA, Senior Medical Writer, Artcraft Health Informed patients make for compliant participants, compliant participants deliver verifiable data. This equation leads to the deliver...
By Marc Sirockman • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Move Aside, Paper: Capturing Clinical trial Outcomes in the Digital Age
There has been much discussion throughout the healthcare industry about providing a positive patient experience and encouraging patients to have more of a voice in their treatment options. Stakeholders have come to recognize that patients have valuable information to share about their experiences...
By Mark Wade • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Thailand Makes Great Strides in Healthcare
With a growing pharmaceutical market, renowned biotechnology research programs, and strong government support for the industry, Thailand has much to recommend it to the global pharma industry. The Kingdom of Thailand, a country with a population of 70 million people, is regarded as newly industri...
By Kim Ribbink • May 29, 2014 -
PharmaVoice Team/PharmaVoice
2014 DIA Preview
2014 DIA Preview New tools, services, and products to improve drug development — as well as personnel appointments — from DIA exhibitors. This year marks the 50th Anniversary of the Annual Meeting of the Drug Information Association, the largest multidisciplinary event that brings together a glob...
By Taren Grom • May 29, 2014
Previous
